These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4345786)

  • 1. Chronic active hepatitis and Graves' disease.
    Thompson WG; Hart IR
    Am J Dig Dis; 1973 Feb; 18(2):111-9. PubMed ID: 4345786
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum long acting thyroid stimulator protector in pregnancy complicated by Graves' disease.
    Hardisty CA; Munro DS
    Br Med J (Clin Res Ed); 1983 Mar; 286(6369):934-5. PubMed ID: 6403139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum long acting thyroid stimulator (LATS) and LATS-protector (LATS-P) in Graves' disease associated with localized myxedema.
    Hardisty CA; Fowles A; Munro DS
    J Endocrinol Invest; 1984 Apr; 7(2):151-5. PubMed ID: 6547156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The assay of Graves' immunoglobulins: a comparison of different methods.
    Hardisty CA; Kendall-Taylor P; Atkinson S; Humphries H; Munro DS
    Clin Endocrinol (Oxf); 1983 Jun; 18(6):637-44. PubMed ID: 6136348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prediction of relapse after drug treatment of Graves' disease by assay of long acting thyroid stimulator-protector (LATS-P).
    Hardisty CA; Hanford L; Munro DS
    Clin Endocrinol (Oxf); 1981 May; 14(5):509-17. PubMed ID: 6895487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibodies pathognomic for Graves-Basedowu disease. I. Methodological aspects of their determination].
    Ryzewska M; Nauman J
    Endokrynol Pol; 1981; 32(2):159-69. PubMed ID: 6895195
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-acting thyroid stimulator and thyroid function in relatives of patients with Graves' disease.
    Bonnyns M; Vanhaerlst L; Golstein J; Cauchie C; Ermans AM; Bastenie PA
    Clin Endocrinol (Oxf); 1973 Jul; 2(3):277-87. PubMed ID: 4128244
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunological aspects of Graves' disease and importance of thyroid stimulating immunoglobulins.
    Bech K
    Acta Endocrinol Suppl (Copenh); 1983; 254():3-38. PubMed ID: 6191508
    [No Abstract]   [Full Text] [Related]  

  • 9. Indirect immunofluorescence and generation of cyclic-AMP investigation with Graves' patients' sera.
    Szabó J; Fórizs E; Szabó T; Leövey A
    Acta Med Hung; 1986; 43(3):275-81. PubMed ID: 3035480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Human thyroid stimulator (HTS) in thyroid diseases].
    Hu ZY
    Zhonghua Nei Ke Za Zhi; 1984 Aug; 23(8):480-3, 525. PubMed ID: 6548953
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathogenesis of neonatal Graves' disease.
    McKenzie JM; Zakarija M
    J Endocrinol Invest; 1978 Apr; 1(2):183-9. PubMed ID: 385703
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-acting thyroid stimulator and related factors.
    Kendall-Taylor P; Dirmikis SM; Munro DS
    Proc R Soc Med; 1975 Apr; 68(4):252-3. PubMed ID: 1242809
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-acting thyroid stimulator (LATS) and long acting thyroid stimulator protector (LATS-P) in untreated thyrotoxicosis.
    Hardisty CA; Hanford L; Humphries H; Munro DS
    Clin Endocrinol (Oxf); 1981 Jun; 14(6):631-9. PubMed ID: 6895353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific and nonspecific responses in the bioassay of long-acting thyroid stimulator (LATS).
    Chopra IJ; Solomon DH; Limberg NP
    J Clin Endocrinol Metab; 1970 Oct; 31(4):382-90. PubMed ID: 5468701
    [No Abstract]   [Full Text] [Related]  

  • 15. A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease.
    McKenzie JM; Zakarija M
    J Clin Endocrinol Metab; 1976 Apr; 42(4):778-81. PubMed ID: 177449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The eye changes of Graves' disease: overview.
    Werner SC
    Mayo Clin Proc; 1972 Dec; 47(12):969-74. PubMed ID: 4564711
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunoglobulin G inhibitor of thyroid-stimulating antibody is a cause of delay in the onset of neonatal Graves' disease.
    Zakarija M; McKenzie JM; Munro DS
    J Clin Invest; 1983 Oct; 72(4):1352-6. PubMed ID: 6138363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunologic basis of Graves's disease.
    Volpé R
    N Engl J Med; 1972 Aug; 287(9):463-4. PubMed ID: 5068098
    [No Abstract]   [Full Text] [Related]  

  • 19. Supervoltage orbital radiotherapy for Graves' ophthalmopathy.
    Donaldson SS; Bagshaw MA; Kriss JP
    J Clin Endocrinol Metab; 1973 Aug; 37(2):276-85. PubMed ID: 4198257
    [No Abstract]   [Full Text] [Related]  

  • 20. [Relation between Basedow's disease and Hashimoto thyroiditis].
    Földes J; Takó J; Bános C; Gesztesi E; Juhász J
    Endokrinologie; 1971 Apr; 57(3):329-37. PubMed ID: 5108742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.